Form 4: Elanco Animal Health: CEO Acquires Deferred Stock Units

Elanco Animal Health CEO Jeffrey N. Simmons acquired 116.9603 deferred stock units on June 12, 2026, valued at $24.17 per unit.

Summary

• Jeffrey N. Simmons, President, CEO, and Director of Elanco Animal Health Inc., acquired 116.9603 deferred stock units on June 12, 2026.
• Each deferred stock unit represents the right to receive one share of Elanco's common stock or its cash equivalent.
• The acquisition was made under a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c) affirmative defense conditions.
• The total value of the acquired deferred stock units was $24,170.00, based on a price of $24.17 per unit.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, as it represents a planned acquisition of deferred stock units by the CEO, indicating continued alignment with shareholder interests.

Positives

• CEO's acquisition of deferred stock units indicates confidence in the company's future prospects.
• The transaction was made under a Rule 10b5-1(c) plan, suggesting a pre-planned and orderly acquisition.
• The acquisition of 116.9603 units shows continued investment by key leadership.

Future Outlook

Deferred stock units are set to settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with the Executive Deferral and Stock Match Plan.

Industry Context

StockSavvy.ai notes that insider transactions, particularly by CEOs, are closely watched by the market as they can signal management's conviction about the company's valuation and future performance within the animal health sector.

Stakeholder Impact

• Shareholders: The CEO's acquisition may be viewed positively, signaling confidence and alignment of interests.
• Employees: The deferred stock unit plan is part of executive compensation, impacting management incentives.

Next Steps

• Settlement of deferred stock units in cash or shares upon termination of employment or during a specified future year.

Key Dates

Keywords

Elanco Animal Health, ELAN, Form 4, Insider Transaction, Deferred Stock Units, CEO, Securities Exchange Act